MedTrace Logo

COVID-19 And Lingering Symptoms In Primary Care Patients

NCT04813731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-09-04

No results posted yet for this study

Summary

The ongoing corona virus disease 2019 (COVID-19) is a viral acute respiratory tract infection caused by server acute respiratory syndrom coronavirus typ 2 (SARS-CoV-2). The signs and symptom of SARS-CoV-2 infection vary and most people with COVID-19 experience illness of mild or moderate severity and recover with symptomatic treatment outside of hospital. Studies have found that some people experience lingering/long-lasting symptoms and only a minority of patients were completely free from COVID-19 related symptoms after two months. About one third still had up to two residual symptoms and 55% had three or more. As far as we know no study on lingering symptoms has been published in patients after a mild or moderate infection managed in primary care settings. The aim of this study is to explore the course of disease over a one year period and describe lingering symptoms and their impact on well-being and daily activities in adult non-hospitalized patients with previous established COVID-19 infection.

Conditions

  • Covid19
  • Symptoms and Signs

Sponsors & Collaborators

  • Research Unit for General Practice in Aalborg

    collaborator OTHER

  • Utrecht University

    collaborator OTHER

  • National University of Ireland, Galway, Ireland

    collaborator OTHER

  • Region Jönköping County

    collaborator OTHER_GOV

  • Katarina Hedin

    lead OTHER_GOV

Principal Investigators

  • Katarina Hedin, Assoc Prof · Region Jönköping County Sweden

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-12
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Belgium
  • Denmark
  • France
  • Georgia
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Poland
  • Romania
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04813731 on ClinicalTrials.gov